Trial intelligence / Profile preview

Washed Microbiota Transplantation for Rhinitis

NCT06350448Not yet recruiting

Sponsor
The Second Affiliated Hospital of Nanjing Medical University
Start
May 2024
Primary completion
May 2029
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Open-label, single-arm trial of washed microbiota transplantation in rhinitis, sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoint: Reflective Total Nasal Symptom Score at 12 weeks. Planned start May 2024; status: not yet recruiting.

02

Drugs

washed microbiota transplantation
03

Conditions

rhinitis

Beyond the preview

Go deeper on NCT06350448.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06350448.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call